My Layman's view and some initial research suggests yet another pillar for Neurizon to build upon.ConclusionIn summary, the benefits of neuroplasticity include improved learning, memory, recovery from brain injuries, adaptability with age, and emotional resilience, with potential to assist conditions like stroke, Traumatic Brain Injury, Alzheimer’s, Parkinson’s, MS, depression, anxiety, and learning disabilities. Neurizon’s announcement on April 1, 2025, underscores NUZ-001’s promising pre-clinical results in promoting neuroplasticity, offering hope for ALS and other neurodegenerative diseases, with planned clinical trials in 2025 to validate these findings.
Lot's more research to do on today's announcement.
Cheers
- Forums
- ASX - By Stock
- NUZ
- Ann: NUZ-001 Shows Positive Results in Human 3D Brain Model
NUZ
neurizon therapeutics limited
Add to My Watchlist
2.94%
!
16.5¢

Ann: NUZ-001 Shows Positive Results in Human 3D Brain Model, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $81.23M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.5¢ | $23.56K | 141.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 30232 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 13227 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 30232 | 0.165 |
5 | 90620 | 0.160 |
6 | 93000 | 0.155 |
5 | 326500 | 0.150 |
1 | 10000 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 13227 | 2 |
0.175 | 181003 | 3 |
0.180 | 21662 | 2 |
0.185 | 150125 | 4 |
0.190 | 24925 | 2 |
Last trade - 15.37pm 24/06/2025 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |